Concentrations of the secondary bile acid, deoxycholic acid (DCA), are aberrantly elevated in colorectal cancer (CRC) patients, but the consequences remain poorly understood. Here, we screened a library of gut microbiota-derived metabolites and identified DCA as a negative regulator for CD8+ T cell effector function. Mechanistically, DCA suppressed CD8+ T cell responses by targeting plasma membrane Ca2+ ATPase (PMCA) to inhibit Ca2+-nuclear factor of activated T cells (NFAT)2 signaling. In CRC patients, CD8+ T cell effector function negatively correlated with both DCA concentration and expression of a bacterial DCA biosynthetic gene. Bacteria harboring DCA biosynthetic genes suppressed CD8+ T cells effector function and promoted tumor growth in mice. This effect was abolished by disrupting bile acid metabolism via bile acid chelation, genetic ablation of bacterial DCA biosynthetic pathway, or specific bacteriophage. Our study demonstrated causation between microbial DCA metabolism and anti-tumor CD8+ T cell response in CRC, suggesting potential directions for anti-tumor therapy.
Pubmed ID: 38479384 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets TNF-alpha
View all literature mentionsThis polyclonal targets Interferon gamma antibody
View all literature mentionsThis monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets CD8α
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets IgG (H+L)
View all literature mentionsThis monoclonal targets PMCA1
View all literature mentionsThis monoclonal targets PMCA4
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets Lamin B1
View all literature mentionsThis polyclonal targets Phospho-PLCgamma1 (Tyr783)
View all literature mentionsThis unknown targets LAT, phospho (Tyr191)
View all literature mentionsThis polyclonal targets Phospho-Src Family (Tyr416)
View all literature mentionsThis monoclonal targets Phospho-Zap-70 (Tyr319)/Syk (Tyr352)
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis monoclonal targets Beta Actin
View all literature mentionsThis monoclonal targets NFAT2
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets IL-4
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets TNF
View all literature mentionsThis monoclonal targets TNF-alpha
View all literature mentionsThis monoclonal targets TCR beta chain
View all literature mentionsThis monoclonal targets CD366
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets TNF-alpha
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets TCR beta chain
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD69
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets TOX
View all literature mentionsThis monoclonal targets TOX
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis recombinant monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentionsMus musculus with name C57BL/6JGpt-Rag1em1Cd3259/Gpt from IMSR.
View all literature mentionsMus musculus with name C57BL/6JGpt from IMSR.
View all literature mentionsMus musculus with name STOCK Nr1h4tm1Gonz/J from IMSR.
View all literature mentionsCell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)
View all literature mentionsMus musculus with name B6.129S4-Vdrtm1Mbd/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6N-Gpbar1tm1(KOMP)Vlcg/MbpMmucd from MMRRC.
View all literature mentionsMus musculus with name B6.129S4-Vdrtm1Mbd/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6N-Gpbar1tm1(KOMP)Vlcg/MbpMmucd from MMRRC.
View all literature mentionsThis polyclonal targets TNF-alpha
View all literature mentionsThis polyclonal targets Interferon gamma antibody
View all literature mentionsThis monoclonal targets CD8α
View all literature mentionsThis monoclonal targets Granzyme B
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets IgG (H+L)
View all literature mentionsThis monoclonal targets PMCA1
View all literature mentionsThis monoclonal targets PMCA4
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets Lamin B1
View all literature mentionsThis polyclonal targets Phospho-PLCgamma1 (Tyr783)
View all literature mentionsThis unknown targets LAT, phospho (Tyr191)
View all literature mentionsThis polyclonal targets Phospho-Src Family (Tyr416)
View all literature mentionsThis monoclonal targets Phospho-Zap-70 (Tyr319)/Syk (Tyr352)
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis monoclonal targets Beta Actin
View all literature mentionsThis monoclonal targets NFAT2
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets IL-4
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets TNF
View all literature mentionsThis monoclonal targets TNF-alpha
View all literature mentionsThis monoclonal targets TCR beta chain
View all literature mentionsThis monoclonal targets CD366
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets TNF-alpha
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets TCR beta chain
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD69
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets TOX
View all literature mentionsThis monoclonal targets TOX
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis recombinant monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD45.2
View all literature mentions